Alignment Healthcare, INC Form 4 insider transactions

Hyong Kim, Chief Medical Officer of Alignment Healthcare, sold 22,460 shares of common stock on October 8, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Alignment Healthcare's CEO, John Kao, sold 90,000 shares of common stock at an average price of $11.3282 on October 9, 2024, under a pre-arranged 10b5-1 trading plan.

Robert Thomas Freeman, CFO of Alignment Healthcare, sold 39,320 shares of common stock at an average price of $12.0384 under a pre-arranged 10b5-1 trading plan.

Christopher J. Joyce, Chief Legal and Administrative Officer of Alignment Healthcare, sold 667 shares of common stock at a weighted-average price of $11.7927 on October 1, 2024.

Robert Freeman, CFO of Alignment Healthcare, sold shares of common stock in early October, according to a recent SEC Form 4 filing.

Dawn Christine Maroney, President of Markets at Alignment Healthcare, sold 30,000 shares of common stock on September 16, 2024, at a weighted-average price of $11.7009.

Director Joseph S. Konowiecki sold 16,413 shares of Alignment Healthcare to cover tax withholding obligations related to vesting restricted stock units on September 17, 2024.

Alignment Healthcare's CEO, John Kao, sold 90,000 shares of common stock on September 16, 2024, under a pre-arranged 10b5-1 trading plan.

Hakan Kardes, Chief Experience Officer of Alignment Healthcare, sold 25,000 shares of common stock on September 12, 2024, at a weighted-average price of $11.4821 per share.

Christopher J. Joyce, Chief Legal and Administrative Officer of Alignment Healthcare, sold shares to cover tax withholding obligations related to vesting restricted stock units and also pursuant to a pre-arranged 10b5-1 trading plan.

Director Joseph Konowiecki sold 50,000 shares of Alignment Healthcare (ALHC) common stock over two days, September 12th and 13th, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Robert Thomas Freeman, CFO of Alignment Healthcare, sold shares of common stock over three days in September 2024.

Christopher J. Joyce, Chief Legal and Administrative Officer of Alignment Healthcare, sold a total of 5,841 shares of common stock in two transactions on September 4th and 5th, 2024.

Robert Thomas Freeman, CFO of Alignment Healthcare, recently sold shares of the company's common stock in a series of transactions.

Dawn Maroney, President of Markets at Alignment Healthcare, sold a portion of her holdings in two transactions on August 22 and 23, 2024.

Dawn Christine Maroney, President of Markets at Alignment Healthcare, sold 20,000 shares of common stock at a weighted-average price of $8.701 on August 15, 2024.

Jeffrey Margolis, a director at Alignment Healthcare, sold 1,200 shares of common stock at $8.83 per share on August 14, 2024.

Christopher Joyce, Chief Legal and Administrative Officer of Alignment Healthcare, sold a portion of his common stock holdings on August 2, 2024.

Joseph S. Konowiecki, a director at Alignment Healthcare, recently sold a portion of his holdings in the company's common stock.

Dawn Christine Maroney, President of Markets at Alignment Healthcare, recently sold a portion of her holdings in the company's common stock.

Robert Thomas Freeman, CFO of Alignment Healthcare, sold a significant number of shares over three days in July.

Hakan Kardes, Chief Experience Officer of Alignment Healthcare, sold 25,000 shares of common stock at $9.98 per share on July 16, 2024.

Joseph Konowiecki, Chairman of the Board at Alignment Healthcare, recently sold shares of the company's common stock.

Jeffrey Margolis, a director at Alignment Healthcare, sold 1,200 shares of common stock on July 15, 2024, at a price of $8.94 per share.

Christopher Joyce, Chief Legal and Administrative Officer of Alignment Healthcare, sold a portion of his holdings in the company's common stock.

Dawn Christine Maroney, President of Markets at Alignment Healthcare, sold shares of common stock in two transactions on July 12 and July 15, 2024.

Christopher Joyce, Chief Legal and Administrative Officer of Alignment Healthcare, sold 666 shares of common stock at an average price of $8.00-$8.01 on July 1, 2024.

Christopher J. Joyce, Chief Legal and Administrative Officer of Alignment Healthcare, sold 16,000 shares of common stock at an average price of $8.0124 on June 14, 2024.

Director Jeffrey Margolis sold 1,200 shares of Alignment Healthcare (ALHC) at $8.06 per share on June 14, 2024.

Dawn Christine Maroney, President of Markets at Alignment Healthcare, sold 20,000 shares of common stock at an average price of $8.21 on June 12, 2024.